Subject: March: ILC 2021, 2nd round of abstracts, multidisciplinarity & more
From: EASL Office <[email-masked]>
To: [email-masked]
Date: Thu, 25 Mar 2021 13:45:49 +0000

A-TANGO launches | COVID-Hep version 2.0 & more

25 March 2021

Read online

Looking back on March

Last  month ended with Rare Disease Day, including our focus on people living with rare liver diseases. March has brought us the relaunch of the COVID-Hep Registry 2.0, the launch of the A-TANGO Consortium, calls for new talent in EASL leadership closing next Monday, 31 March, and news relating to ILC 2021. Read about it below.

Ready, steady, go for ILC 2021

Calling for abstract submissions for ILC 2021 in a second round

EASL is pleased to announce the second round of abstract submissions for ILC 2021. We are calling for scientists, researchers, investigators, and companies to submit regular and high-profile, late-breaker abstracts, 10–27 April 2021.

In line with EASL’s commitment to make ILC 2021 the platform of choice for liver research from around the world, we encourage researchers to submit their most recent work – be it late-breaking results or work that simply was not ready earlier in the year.

Read more about preparing your abstract

The International Liver Congress™ 2021 is all about beating liver disease  together. We will tackle this challenge from multiple perspectives, drawing on multidisciplinary expertise, with input from all four corners of the globe.

Multidisciplinarity – what horizons is this approach opening up?

Multidisciplinary approaches to the health sciences are increasingly in demand – calling on multiple disciplines to tackle diseases from bench to bedside, from R&D through to patient care. Opportunities to publish this cross-cutting research are also on the increase, opening up new career horizons for investigators and other healthcare professionals.

Here are just a few examples of how ILC 2021 is showcasing multidisciplinarity:

From nurses and AHPs: The art and science of collaborative working

In the Postgraduate Course: Multidisciplinary outpatient approach to non-alcohol related fatty liver disease (NAFLD) and alcohol-related disease (ALD)

IgG4-RD multidisciplinary team meeting with clinical cases, from a panel of experts, & more.

Register for ILC 2021 and bookmark sessions that will make your programme align perfectly with your needs and interests.

Explore multidisciplinarity at ILC 2021

Register now

COVID-Hep Registry relaunches version 2.0, with EASL support

EASL is proud to support the launch of the COVID-Hep Registry version 2.0.

This collaborative, global registry collects data on patients with liver disease at any stage or with liver transplants who have also developed laboratory-confirmed COVID-19.

We encourage you to share the registry among your networks!

Read more about the registry

News from EASL's EU-funded projects: A-TANGO Consortium launches

The A-TANGO Consortium, a five-year project, consists of 14 institutions across eight countries in Europe. It aims to perform Phase II clinical studies of an innovative therapeutic strategy that targets inflammation and improves liver regeneration – a novel combinatorial therapy called “G-TAK”. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 945096.

Read the full press release

EASL serves as the dissemination arm of several EU-funded projects, including A-TANGO. Accordingly, we will provide support to A-TANGO, using our established communication channels to reach the wider liver community.

View EASL's EU-funded projects

Check out what's happening in EASL education

Catch up on recent EASL Campus materials

Ask EASL podcast on COVID-19 vaccination in patients with liver disease

Viral hepatitis elimination webcast

COVID-19 vaccination in patients with liver disease, on-demand webinar, and more

Explore more on EASL Campus

Latest publications

Are you keeping up with scientific developments released in our monthly EASL journals, published with Elsevier? Highlights from the latest issues appear below.

Sign up to become an EASL member and enjoy an online subscription to the Journal of Hepatology, plus a 50% discount on the open-access publication fees for JHEP Reports.

Journal of Hepatology

Volume 74, Issue 4

HCV-seropositive donors to HCV-seronegative recipients, & more

Browse the Table of Contents

Read "From the Editors' Desk", Selection of the month: Liver transplantation from HCV-seropositive donors to HCV-seronegative recipients

View the lay summaries archives

JHEP Reports

Volume 3, Issue 2

Fatty liver disease and bile acids, hepatocellular carcinoma (HCC), cirrhosis & liver failure.

Browse the Table of Contents

Read the Editorial: The third year

View the lay summaries

Are you keen to see your research published? Consult the manuscript submission guidelines for JHEP Reports so you can polish up your manuscript to submit it.

Download the EASL app

Access event info, EASL Campus and stay informed with the latest messages and news.

For the latest news on our events, follow us on Twitter

@EASLnews and @EASLedu

Share with a friend or colleague

You received this email, because in your previous interaction with EASL, you indicated your speciality and areas of particular interest. To update your preferences, please go to your MyEASL profile.

Copyright © 2021 EASL, The Home of Hepatology, All rights reserved.

Our mailing address is:

EASL, The Home of Hepatology

7 rue Daubin, 1203 Geneva, Switzerland

+41 22 807 03 60

www.easl.eu

[email-masked]

Update your preferences or unsubscribe